Goodwin Procter advised HIBio on the deal while Orrick represented MorphoSys. HIBio announced its equity participation agreement and license agreements with MorphoSys AG (FSE: MOR; NASDAQ: MOR)....
HIBio’s License Agreements with MorphoSys AG
NuOrder’s $45 Million Series E Round
Orrick Herrington & Sutcliffe LLP advised NuOrder on the deal. NuORDER, the leading B2B e-commerce platform announces it has raised $45 million in a round led by Brighton...